Sam Chun Dang Pharm Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sam Chun Dang Pharm Co Ltd with three other
companies in this sector in South Korea:
Bukwang Pharmaceutical Company Limited
sales of 150.74 billion Korean Won [US$141.55 million]
of which 100%
Whanin Pharmaceutical Company Limited
(147.95 billion Korean Won [US$138.93 million]
of which 78%
was Riperidon &Quetapin etc.), and
JW Life Science Corp
(143.60 billion Korean Won [US$134.84 million]
Sam Chun Dang Pharm Co Ltd reported sales of 161.11 billion Korean Won (US$151.28 million)
December of 2017.
increase of 9.3%
versus 2016, when the company's sales were 147.37 billion Korean Won.
Sales at Sam Chun Dang Pharm Co Ltd have increased during each of the previous five years
(and since 2012, sales have increased a total of 110%).